Bank of New York Mellon’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-36,570
Closed -$1M 4370
2015
Q1
$1M Buy
+36,570
New +$1.01M ﹤0.01% 3308
2014
Q3
Sell
-39,769
Closed -$1.25M 4265
2014
Q2
$1.25M Sell
39,769
-342,222
-90% -$10.9M ﹤0.01% 3186
2014
Q1
$12.4M Sell
381,991
-1,111,983
-74% -$38.9M ﹤0.01% 1769
2013
Q4
$54.3M Sell
1,493,974
-871,163
-37% -$33.9M 0.02% 843
2013
Q3
$92M Sell
2,365,137
-34,129
-1% -$1.37M 0.03% 586
2013
Q2
$89.9M Buy
+2,399,266
New +$94.7M 0.03% 566

Other funds holding MR

Bank of New York Mellon's MR Position: Q2 2015 in Review

Bank of New York Mellon sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q2 2015, closing a stake of 36,570 shares — an estimated $1M sold.

Bank of New York Mellon first reported a position in MR in Q2 2013 and held it in 6 quarters. The position peaked at $92M in Q3 2013. 118 funds tracked by Wall St. Rank hold MR as of Q2 2015.

  • Bank of New York Mellon reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q2 2015 after selling out during the quarter.
  • Bank of New York Mellon sold 36,570 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q2 2015, an estimated $1M.
  • Bank of New York Mellon first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 6 quarters.
  • Bank of New York Mellon's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $92M in Q3 2013.
  • 118 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q2 2015.

Based on Bank of New York Mellon's 13F filing for Q2 2015, filed 6 Aug 2015.